January 2015

The Universities of Edinburgh and Glasgow established the Scottish Genomes Partnership with a £15m investment.

10 state-of-the-art Illumina HiSeq X genome sequencing instruments were purchased and installed at Edinburgh Genomics and the Glasgow Precision Oncology Laboratory.

​​

February 2016

​

The Scottish Genomes Partnership received £6m in research funding from Scotland’s Chief Scientist Office (£4m) and the UK’s Medical Research Council (£2m), creating a pan-Scotland research partnership.

This funding brought significant research opportunities, including major collaborations with Genomics England and AstraZeneca.

​

With this funding, scientists explored causes of central nervous system disorders, developmental disorders, and cancer, as well as examining genes which influence risk factors for common, complex diseases in a Scottish population.

​

September 2018

​

Following on from the SGP research, the Scottish Government announced a £4.2m investment in genomics services as part of its Programme for Government 2018-19.

​